{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:25:30Z","timestamp":1792113930384,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100022654","name":"Hudfonden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022654","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Science Council"},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012331","name":"Leo foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ALF medicin Stockholm"},{"name":"Jeanssons stiftelse"},{"DOI":"10.13039\/501100011898","name":"Marcus och Amalia Wallenbergs minnesfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011898","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tore Nilssons Stiftelse"},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Darier disease (DD) is a rare monogenetic skin disorder with limited data on its potential association with neurological disorders. This study aimed to investigate the association between DD and neurological disorders, specifically Parkinson's disease, dementias, and epilepsy. Using Swedish national registers in a period spanning between 1977 and 2013, 935 individuals with DD were compared with up to 100 comparison individuals each, randomly selected from the general population based on birth year, sex, and county of residence at the time of the first diagnosis of DD. Individuals with DD had increased risks of being diagnosed with Parkinson's disease (RR 2.1, CI 1.1; 4.4), vascular dementia (RR 2.1, CI 1.0; 4.2), and epilepsy, (RR 2.5, CI 1.8; 3.5). No association of DD with other dementias were detected. This study demonstrates a new association between DD and neurodegenerative disorders and epilepsy, underlining the need for increased awareness, interdisciplinary collaboration, and further research to understand the underlying mechanisms. Early identification and management of neurological complications in DD patients could improve treatment strategies and patient outcomes. The findings also highlight the role of SERCA2 in the pathophysiology of neurological disorders, offering new targets for future research and potentials for novel treatments.<\/jats:p>","DOI":"10.1038\/s41598-024-57779-4","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T08:10:34Z","timestamp":1711440634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Darier disease is associated with neurodegenerative disorders and epilepsy"],"prefix":"10.1038","volume":"14","author":[{"given":"Philip","family":"Curman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jebril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etty","family":"Bachar-Wikstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cederl\u00f6f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob D.","family":"Wikstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"issue":"1","key":"57779_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0190-9622(92)70154-8","volume":"27","author":"SM Burge","year":"1992","unstructured":"Burge, S. M. & Wilkinson, J. D. Darier-White disease: A review of the clinical features in 163 patients. J. Am. Acad. Dermatol. 27(1), 40\u201350 (1992).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"57779_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/6784","volume":"21","author":"A Sakuntabhai","year":"1999","unstructured":"Sakuntabhai, A. et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat. Genet. 21(3), 271\u2013277. https:\/\/doi.org\/10.1038\/6784 (1999).","journal-title":"Nat. Genet."},{"key":"57779_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-030-12457-1_6","volume":"1131","author":"A Britzolaki","year":"2020","unstructured":"Britzolaki, A., Saurine, J., Klocke, B. & Pitychoutis, P. M. A role for SERCA pumps in the neurobiology of neuropsychiatric and neurodegenerative disorders. Adv. Exp. Med. Biol. 1131, 131\u2013161. https:\/\/doi.org\/10.1007\/978-3-030-12457-1_6 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"44","key":"57779_CR4","doi-asserted-by":"publisher","first-page":"18533","DOI":"10.1073\/pnas.0906797106","volume":"106","author":"I Vandecaetsbeek","year":"2009","unstructured":"Vandecaetsbeek, I. et al. Structural basis for the high Ca2+ affinity of the ubiquitous SERCA2b Ca2+ pump. Proc. Natl. Acad. Sci. USA. 106(44), 18533\u201318538. https:\/\/doi.org\/10.1073\/pnas.0906797106 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"2","key":"57779_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2165\/00128071-200304020-00003","volume":"4","author":"SM Cooper","year":"2003","unstructured":"Cooper, S. M. & Burge, S. M. Darier\u2019s disease: Epidemiology, pathophysiology, and management. Am. J. Clin. Dermatol. 4(2), 97\u2013105 (2003).","journal-title":"Am. J. Clin. Dermatol."},{"issue":"3","key":"57779_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/bdi.12257","volume":"17","author":"M Cederlof","year":"2015","unstructured":"Cederlof, M. et al. The association between Darier disease, bipolar disorder, and schizophrenia revisited: A population-based family study. Bipolar Disord. 17(3), 340\u2013344. https:\/\/doi.org\/10.1111\/bdi.12257 (2015).","journal-title":"Bipolar Disord."},{"issue":"3","key":"57779_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1192\/bjp.164.3.355","volume":"164","author":"N Craddock","year":"1994","unstructured":"Craddock, N. et al. Familial cosegregation of major affective disorder and Darier\u2019s disease (keratosis follicularis). Br. J. Psychiatry. 164(3), 355\u2013358. https:\/\/doi.org\/10.1192\/bjp.164.3.355 (1994).","journal-title":"Br. J. Psychiatry."},{"issue":"5","key":"57779_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10571-018-0583-8","volume":"38","author":"A Britzolaki","year":"2018","unstructured":"Britzolaki, A., Saurine, J., Flaherty, E., Thelen, C. & Pitychoutis, P. M. The SERCA2: A gatekeeper of neuronal calcium homeostasis in the brain. Cell Mol. Neurobiol. 38(5), 981\u2013994. https:\/\/doi.org\/10.1007\/s10571-018-0583-8 (2018).","journal-title":"Cell Mol. Neurobiol."},{"key":"57779_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-94-007-5561-1_5","volume":"12","author":"M Brini","year":"2013","unstructured":"Brini, M., Cal\u00ec, T., Ottolini, D. & Carafoli, E. Intracellular calcium homeostasis and signaling. Met. Ions Life Sci. 12, 119\u2013168. https:\/\/doi.org\/10.1007\/978-94-007-5561-1_5 (2013).","journal-title":"Met. Ions Life Sci."},{"issue":"1","key":"57779_CR10","doi-asserted-by":"publisher","first-page":"6886","DOI":"10.1038\/s41598-020-63832-9","volume":"10","author":"E Bachar-Wikstrom","year":"2020","unstructured":"Bachar-Wikstrom, E. et al. Darier disease is associated with heart failure: a cross-sectional case-control and population based study. Sci. Rep. 10(1), 6886. https:\/\/doi.org\/10.1038\/s41598-020-63832-9 (2020).","journal-title":"Sci. Rep."},{"issue":"6","key":"57779_CR11","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jaad.2019.05.087","volume":"81","author":"M Cederl\u00f6f","year":"2019","unstructured":"Cederl\u00f6f, M. et al. Darier disease is associated with type 1 diabetes: Findings from a population-based cohort study. J. Am. Acad. Dermatol. 81(6), 1425\u20131426. https:\/\/doi.org\/10.1016\/j.jaad.2019.05.087 (2019).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"57779_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2340\/00015555-3818","volume":"101","author":"P Curman","year":"2021","unstructured":"Curman, P. et al. Patients with darier disease exhibit cognitive impairment while patients with hailey-hailey disease do not: an experimental, matched case-control study. Acta Derm. Venereol. 101(6), 476. https:\/\/doi.org\/10.2340\/00015555-3818 (2021).","journal-title":"Acta Derm. Venereol."},{"issue":"4","key":"57779_CR13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1073\/pnas.1119675109","volume":"109","author":"O Zuk","year":"2012","unstructured":"Zuk, O., Hechter, E., Sunyaev, S. R. & Lander, E. S. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. USA. 109(4), 1193\u20131198. https:\/\/doi.org\/10.1073\/pnas.1119675109 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"57779_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson, J. F. et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 11, 450. https:\/\/doi.org\/10.1186\/1471-2458-11-450 (2011).","journal-title":"BMC Public Health."},{"issue":"2","key":"57779_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson, J. F. et al. Registers of the Swedish total population and their use in medical research. Eur. J. Epidemiol. 31(2), 125\u2013136. https:\/\/doi.org\/10.1007\/s10654-016-0117-y (2016).","journal-title":"Eur. J. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57779-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T08:12:23Z","timestamp":1711440743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57779-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["57779"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-57779-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"assertion":[{"value":"17 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Henrik Larsson reports receiving grants from Shire Pharmaceuticals; personal fees from and serving as a speaker for Medice, Shire\/Takeda Pharmaceuticals and Evolan Pharma AB; and sponsorship for a conference on attention-deficit\/hyperactivity disorder from Shire\/Takeda Pharmaceuticals and Evolan Pharma AB, all outside the submitted work. Henrik Larsson is editor-in-chief of JCPP Advances. The other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7109"}}